• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2012 Fiscal Year Final Research Report

Characterization of tumorigenic stem cells in myeloid neoplasms

Research Project

  • PDF
Project/Area Number 22249039
Research Category

Grant-in-Aid for Scientific Research (A)

Allocation TypeSingle-year Grants
Section一般
Research Field Hematology
Research InstitutionKyushu University

Principal Investigator

AKASHI Koichi  九州大学, 医学研究院, 教授 (80380385)

Co-Investigator(Kenkyū-buntansha) MIYAMOTO Toshihiro  九州大学, 大学病院, 講師 (70343324)
TAKENAKA Katsuto  九州大学, 大学病院, 講師 (30301295)
IWASAKI Hiromi  九州大学, 大学病院, 准教授 (20403925)
Project Period (FY) 2010 – 2012
Keywords腫瘍性幹細胞 / 骨髄増殖性腫瘍 / 骨髄異形成症候群 / 異種移植 / マクロファージ寛容
Research Abstract

To understand the property of tumorigenic stem cells in diverse myeloid neoplasms, it is necessary to develop an efficient xenotransplant model. We established a novel immunodeficient mouse strain that possessed a high capability to reconstitute human hem

  • Research Products

    (17 results)

All 2013 2012 2011 2010 Other

All Journal Article (7 results) (of which Peer Reviewed: 7 results) Presentation (8 results) Remarks (2 results)

  • [Journal Article] TIM-3 as a therapeutic target for malignant stem cells in acute myelogenous leukemia2013

    • Author(s)
      Kikushige Y, Akashi K
    • Journal Title

      Ann NY Acad Sci

      Volume: 1266 Pages: 118-123

    • DOI

      DOI:10.1111/j.1749-6632.2012.06550.x.

    • Peer Reviewed
  • [Journal Article] Polymorphic Sirpa is the genetic determinant for NOD-based mouse lines to achieve efficient human cell engraftment.2013

    • Author(s)
      Yamauchi T, Takenaka K, Urata S, Shima T, Kikushige Y, Tokuyama T, Iwamoto C, Nishihara M, Iwasaki H, Miyamoto T, Honma N, Nakao M, Matozaki T, Akashi K.
    • Journal Title

      Blood

      Volume: 121(8) Pages: 1316-1325

    • DOI

      DOI:10.1182/blood-2012-06-440354

    • Peer Reviewed
  • [Journal Article] Quantitation of hematogones at the time of engraftment is a useful prognostic indicator in allogeneic hematopoietic stem cell transplantation2013

    • Author(s)
      Shima T, Miyamoto T, Kikushige Y, Mori Y, Kamezaki K, Takase K, Henzan H, Numata A, Ito Y, Takenaka K, Iwasaki H, Kamimura T, Eto T, Nagafuji K, Teshima T, Kato K, Akashi K.
    • Journal Title

      Blood

      Volume: 121(5) Pages: 840-848

    • DOI

      DOI:10.1182/blood-2012-02-409607

    • Peer Reviewed
  • [Journal Article] Engulfment of hematopoietic stem cells caused by down-regulation of CD47 is critical in the pathogenesis of hemophagocytic lymphohistiocytosis.2012

    • Author(s)
      Kuriyama T, Takenaka K, Kohno K, Yamauchi T, Daitoku S, Yoshimoto G, Kikushige Y, Kishimoto J, Abe Y, Harada N, Miyamoto T, Iwasaki H, Teshima T, Akashi K
    • Journal Title

      Blood

      Volume: 120(19) Pages: 4058-4067

    • DOI

      DOI:10.1182/blood-2012-02-408864.

    • Peer Reviewed
  • [Journal Article] Self-renewing hematopoietic stem cell is theprimary target in pathogenesis ofhuman chron is lymphocytic leukemia2011

    • Author(s)
      Kikushige Y, Ishikawa F, Miyamoto T, Shima T, Urata S, Yoshimoto G, Mori Y, Iino T, Yamauchi T, Eto T, Niiro H, Iwasaki H, Takenaka K, Akashi K.
    • Journal Title

      Cancer Cell

      Volume: 20(2) Pages: 246-259

    • DOI

      DOI:10.1016/j.ccr.2011.06.029.

    • Peer Reviewed
  • [Journal Article] JAK2 V617F uses distinct signalling pathways to induce cell proliferation and neutrophil activation.2011

    • Author(s)
      Oku S, Takenaka K, Kuriyama T, Shide K, Kumano T, Kikushige Y, Urata S, Yamauchi T, Iwamoto C, Shimoda HK, Miyamoto T, Nagafuji K, Kishimoto J, Shimoda K, Akashi K.
    • Journal Title

      Br J Haematol

      Volume: 150(3) Pages: 334-344

    • DOI

      DOI:10.1111/j.1365-2141.2010.08249.x

    • Peer Reviewed
  • [Journal Article] TIM-3 is a promising target to selectively kill acute myeloid leukemia stem cells.2010

    • Author(s)
      Kikushige Y, Shima T, Takayanagi SI, Urata S, Miyamoto T, Iwasaki H, Takenaka K, Teshima T, Tanaka T, Inagaki Y, Akashi K.
    • Journal Title

      Cell Stem Cell

      Volume: 7(6) Pages: 708-717

    • DOI

      DOI:10.1016/j.stem.2010.11.014.

    • Peer Reviewed
  • [Presentation] Transcription factor regulation of normal and malignant hematopoiesis.2013

    • Author(s)
      Akashi K
    • Organizer
      2013 USA-Japan Science Conference
    • Place of Presentation
      Hawaii,USA
    • Year and Date
      2013-03-26
  • [Presentation] 悪性造血器腫瘍における癌幹細胞の病理2012

    • Author(s)
      赤司浩一
    • Organizer
      第71回日本癌学会
    • Place of Presentation
      札幌
    • Year and Date
      2012-09-21
  • [Presentation] 慢性リンパ性白血病幹細胞の特性と治療応用2012

    • Author(s)
      赤司浩一
    • Organizer
      第10回日本臨床腫瘍学会
    • Place of Presentation
      大阪
    • Year and Date
      2012-07-28
  • [Presentation] 造血器悪性幹細胞の成立機序2012

    • Author(s)
      赤司浩一
    • Organizer
      第101回日本病理学会
    • Place of Presentation
      東京
    • Year and Date
      2012-04-26
  • [Presentation] Transcription factor regulation in normal and malignant hematopoiesis.2011

    • Author(s)
      Akashi K
    • Organizer
      第53回米国血液学会
    • Place of Presentation
      SanDiego,USA
    • Year and Date
      20111200
  • [Presentation] Origin of leukemic stem cells2011

    • Author(s)
      Akashi K
    • Organizer
      ドイツ造血幹細胞学会
    • Place of Presentation
      Tubingen,Gemmany
    • Year and Date
      20110900
  • [Presentation] Leukemic stem cells2011

    • Author(s)
      Akashi K
    • Organizer
      第16回ヨーロッパ血液学会
    • Place of Presentation
      London,UK
    • Year and Date
      20110700
  • [Presentation] 白血病幹細胞を考える2010

    • Author(s)
      赤司浩一
    • Organizer
      第72回日本血液学会総会
    • Place of Presentation
      横浜
    • Year and Date
      2010-09-24
  • [Remarks] 九州大学第一内科

    • URL

      http://www.lnai.med.kyushu-.ac.Jp

  • [Remarks] 新学術領域研究「癌幹細胞を標的とする腫瘍根絶技術の新構築」

    • URL

      http://www.cancer-tem-ell.com

URL: 

Published: 2014-08-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi